Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2011 Dec 7;2:244. doi: 10.3389/fmicb.2011.00244

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2011 Nayak, Sarkar, Perrin, Moghimi, Hoffman, Zhou, Byrne and Herzog.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.

PMC Copyright notice

Comparison of Rapa/specific peptide tolerization protocol using different routes and schedules of drug administration. DO.11.10-tg Rag^−/− mice (n = 4 per group) were treated for 3 weeks with Rapa/ova-specific peptide, after which the spleens were harvested, and flow cytometry was used to determine: (A) percentage of CD4⁺ T cells of total gated splenocytes, and (B) percentage of CD25⁺FoxP3⁺ cells of CD4⁺ T cells. Statistically significant differences between each group and untreated (naïve) control mice are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. In (B), a statistically significant difference between mice that received rapamycin orally three-times per week or daily is also indicated.